Natera

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Natera and other ETFs, options, and stocks.

About NTRA

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). 

CEO
Stephen Chapman
CEOStephen Chapman
Employees
3,293
Employees3,293
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
2003
Founded2003
Employees
3,293
Employees3,293

NTRA Key Statistics

Market cap
11.07B
Market cap11.07B
Price-Earnings ratio
-24.12
Price-Earnings ratio-24.12
Dividend yield
Dividend yield
Average volume
1.15M
Average volume1.15M
High today
$92.83
High today$92.83
Low today
$91.10
Low today$91.10
Open price
$92.00
Open price$92.00
Volume
563.57K
Volume563.57K
52 Week high
$98.82
52 Week high$98.82
52 Week low
$36.90
52 Week low$36.90

NTRA News

Yahoo Finance 9h
Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc - Yahoo Finance

Natera Inc (NASDAQ:NTRA), a leader in personalized genetic testing and diagnostics, has seen a recent insider transaction according to the latest SEC Filing. Th...

Insider Sell: CFO Michael Brophy Sells Shares of Natera Inc - Yahoo Finance
Simply Wall St 1d
Shareholders have faith in loss-making Natera as stock climbs 4.6% in past week, taking five-year ... - Simply Wall St

Long term investing can be life changing when you buy and hold the truly great businesses. While the best companies are hard to find, but they can generate mass...

Shareholders have faith in loss-making Natera as stock climbs 4.6% in past week, taking five-year ... - Simply Wall St
Yahoo Finance 3d
Natera Rose on Momentum in the Oncology Market - Yahoo Finance

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded he...

Natera Rose on Momentum in the Oncology Market - Yahoo Finance

Analyst ratings

89%

of 18 ratings
Buy
88.9%
Hold
5.6%
Sell
5.6%

More NTRA News

Yahoo Finance 3d
CEO and President Steven Chapman Sells Shares of Natera Inc - Yahoo Finance

Steven Chapman, CEO and President of Natera Inc (NASDAQ:NTRA), has sold 2,552 shares of the company on April 23, 2024, according to a recent SEC Filing. This tr...

CEO and President Steven Chapman Sells Shares of Natera Inc - Yahoo Finance
Benzinga 4d
Looking Into Natera's Recent Short Interest - Natera - Benzinga

Loading... Loading... Natera's NTRA short percent of float has fallen 21.4% since its last report. The company recently reported that it has 6.25 million share...

Looking Into Natera's Recent Short Interest - Natera - Benzinga
Yahoo Finance 5d
Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications - Yahoo Finance

Demonstrates commitment to generating real-world clinical evidence to change disease management and improve patient outcomes AUSTIN, Texas, April 22, 2024--(BU...

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.